Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
4.833 INR | -1,03 % | +2,73 % | -7,10 % |
Kurzporträt
Mitarbeiterzahl: 16 871
Umsatz nach Geschäftsbereich
INR in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Pharmaceutical and Related Products
100,0
%
| 106 342 | 100,0 % | 115 993 | 100,0 % | +9,08 % |
Umsatz je Region
INR in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
India
70,3
%
| 75 266 | 70,8 % | 81 600 | 70,3 % | +8,41 % |
United States
21,7
%
| 23 291 | 21,9 % | 25 134 | 21,7 % | +7,91 % |
Other Countries
8,0
%
| 7 785 | 7,3 % | 9 259 | 8,0 % | +18,94 % |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Vikas Gupta
CEO | Chief Executive Officer | - | 22.09.23 |
Nitin Agrawal
DFI | Director of Finance/CFO | - | 01.02. |
Manish Narang
CMP | Compliance Officer | 54 | 01.11.06 |
Sandeep Singh
BRD | Director/Board Member | 41 | 09.08.13 |
Investor Relations Contact | - | - | |
Amit Ghare
PRN | Corporate Officer/Principal | - | 01.01.08 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Director/Board Member | 60 | - | |
Chief Executive Officer | 84 | 08.08.73 | |
Sudha Ravi
BRD | Director/Board Member | 68 | 29.06.15 |
Sandeep Singh
BRD | Director/Board Member | 41 | 09.08.13 |
Director/Board Member | 61 | 01.01.88 | |
Srinivas Singh
BRD | Director/Board Member | - | 01.01.12 |
Sarvesh Singh
BRD | Director/Board Member | 42 | 11.11.19 |
Madhurima Singh
BRD | Director/Board Member | - | 20.12.21 |
Suijain Talwar
BRD | Director/Board Member | - | 05.08.22 |
Aniruddha Singh
BRD | Director/Board Member | 24 | 23.11. |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 119 565 000 | 43 283 695 ( 36,20 %) | 0 | 36,20 % |
Unternehmenskontakt
Alkem Laboratories Ltd.
Devashish Building, Alkem House Senapati Bapat Marg
400013, Mumbai
+91 22 3982 9999
http://www.alkemlabs.comKonzerngesellschaften
Name | Kategorie und Branche |
---|---|
Indchemie Health Specialities Pvt Ltd.
Indchemie Health Specialities Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Alkem Laboratories Ltd., Indchemie Health Specialities Pvt Ltd. is an Indian company that manufactures and markets pharmaceutical products. The private company is based in Mumbai, India. |
Pharmaceuticals: Major
|
Enzene Biosciences Ltd.
Enzene Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Enzene Biosciences Ltd. is a pharmaceutical company based in Pune, IN. The company was founded in 2006. The Indian company's vision is to positively impact the healthcare landscape by delivering reliable and affordable medicines to improve life quality. The CEO is Himanshu Gadgil. Enzene Biosciences was acquired by Alkem Laboratories Ltd. on January 03, 2012. |
Pharmaceuticals: Major
|
Ascend Laboratories LLC
Ascend Laboratories LLC Pharmaceuticals: GenericHealth Technology Part of Alkem Laboratories Ltd., Ascend Laboratories LLC is a pharmaceutical company based in Montvale, NJ. The private company provides high-quality and cost-effective generics that address a number of health issues in several therapeutic areas. Ascend Laboratories is dedicated to improving patient outcomes and reducing the cost of healthcare. The company has experienced significant growth since launching its first product in March of 2008. Ascend Laboratories is committed to customer safety and offers a range of products that are identical or bioequivalent to brand name drugs in dosage form, safety, strength, route of administration, quality, performance characteristics, and intended use. The company is partnering with PursueCare, a national mail-order pharmacy, to ensure that all patients who desire the Ascend brand have easy access to it. |
Pharmaceuticals: Generic
|
Ascend Laboratories SpA
Ascend Laboratories SpA Pharmaceuticals: MajorHealth Technology Part of Alkem Laboratories Ltd., Ascend Laboratories SpA is a Chilean company that manufactures, sells, and retails bioequivalent drugs to improve the health and well-being of patients. The private company is based in Las Condes, Chile. |
Pharmaceuticals: Major
|
S&B Pharma LLC
| |
The Pharma Network LLP
|
Sektor
Umsatz je Region
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-7,10 % | 7 Mrd. | |
+26,47 % | 664 Mrd. | |
+29,02 % | 567 Mrd. | |
-6,33 % | 354 Mrd. | |
+19,35 % | 330 Mrd. | |
+4,23 % | 286 Mrd. | |
+14,21 % | 234 Mrd. | |
+5,00 % | 199 Mrd. | |
-10,02 % | 196 Mrd. | |
-4,04 % | 148 Mrd. |
- Börse
- Aktien
- A2ACU0 Aktie
- Unternehmen Alkem Laboratories Limited